<p>The two private equity consortia vying for Stada have made binding takeover offers each worth 4.7 billion euros ($5.0 billion) including debt, paving the way for a deeper look into the German generic drugmaker‘s books, several people familiar with the matter said.</p>
<p>The competing groups, Advent and Permira against Bain and Cinven, have also secured financing packages, which had been a precondition set by Stada before more business data could be provided, the sources added.</p>